Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN2 | P17706 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
| ▸ | UGT2B7 | P16662 | 4/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1583053 | 1.00 | PTPN2 (0.43) | PTPN2PTPN1UGT2B7 | |
| SCHEMBL813342 | 1.00 | PTPN2 (0.43) | PTPN2PTPN1UGT2B7 | |
| SCHEMBL10971244 | 1.00 | PTPN2 (0.43) | PTPN2PTPN1UGT2B7 | |
| SCHEMBL9617991 | 1.00 | PTPN2 (0.43) | PTPN2PTPN1UGT2B7 | |
| SCHEMBL813344 | 1.00 | PTPN2 (0.43) | PTPN2PTPN1UGT2B7 | |
| SCHEMBL813341 | 1.00 | PTPN2 (0.43) | PTPN2PTPN1UGT2B7 | |
| SCHEMBL954543 | 0.86 | UGT2B7 (0.52) | PTPN2PTPN1UGT2B7 | |
| SCHEMBL9248576 | 0.86 | UGT2B7 (0.52) | PTPN2PTPN1UGT2B7 | |
| SCHEMBL954950 | 0.86 | UGT2B7 (0.52) | PTPN2PTPN1UGT2B7 | |
| SCHEMBL954542 | 0.86 | UGT2B7 (0.52) | PTPN2PTPN1UGT2B7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 551 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3541913-B1 | FABRIC TREATMENT COMPOSITIONS AND METHODS FOR PROVIDING A BENEFIT | PROCTER & GAMBLE (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4711010-A2 | PRO-PERFUME COMPOSITIONS | Firmenich SA (CH) | 2026-03-18 | — | — | EP | claimed |
| US-20260014065-A1 | PHYTOCHEMICAL INFUSED COSMETIC COMPOSITIONS AND THERAPEUTIC USES THEREOF | Dewey Beauty LLC (US) | 2026-01-15 | — | — | US | claimed |
| US-20250325463-A1 | COMPOSITIONS (III) | SYMRISE AG (DE) | 2025-10-23 | — | — | US | claimed |
| CN-119972014-A | Composite gel microsphere capable of efficiently adsorbing fluoride ions as well as preparation method and application thereof | 四川大学 | 2025-05-13 | — | — | CN | claimed |
| CN-119630773-A | Solid soluble compositions | 宝洁公司 | 2025-03-14 | — | — | CN | claimed |
| CN-119585410-A | Low water content compositions | 宝洁公司 | 2025-03-07 | — | — | CN | claimed |
| WO-2025030129-A2 | AEROSOL SPRAY DEVICE, INSECTICIDE COMPOSITION, AND METHOD OF USE | UNITED INDUSTRIES CORPORATION (US) | 2025-02-06 | — | — | WO | claimed |
| EP-4096618-B1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2025-01-29 | — | — | EP | claimed |
| CN-119255781-A | Antimicrobial mixtures | 西姆莱斯股份公司 | 2025-01-03 | — | — | CN | claimed |
| US-6723305-B2 | CONTAINING CETYLPYRIDINIUM CHLORIDE AND ZINC ACETATE | COLGATE PALMOLIVE COMPANY | 2004-04-20 | — | — | US | claimed |
| WO-2003075865-A1 | ANTI-MICROBIAL BREATH FRESHENING MOUTHRINSE | COLGATE-PALMOLIVE COMPANY (US) | 2003-09-18 | — | — | WO | claimed |
| US-20030165439-A1 | Anti-microbial breath freshening mouthrinse | COLGATE-PALMOLIVE COMPANY | 2003-09-04 | — | — | US | claimed |
| EP-0330995-B1 | Bicyclic ethers | GIVAUDAN ROURE INT (CH) | 1994-08-31 | — | — | EP | claimed |
| US-4814163-A | ZINC SALT, MINT FLAVOR, KETONE TERPENE, SODIUM OR POTASSIUM GLUCONATE, ACIDIFICATION, CARRIER | COLGATE-PALMOLIVE COMPANY (US) | 1989-03-21 | — | — | US | claimed |
| US-4814164-A | ZINC COMPOUND, KETONE TERPENE, FLAVOR, CARRIER | COLGATE-PALMOLIVE COMPANY (US) | 1989-03-21 | — | — | US | claimed |
| US-4689214-A | ZINC CHLORIDE AND AN IONONE KETONE TERPENE COMPONENT | COLGATE-PALMOLIVE COMPANY (US) | 1987-08-25 | — | — | US | claimed |
| EP-0047317-B1 | HALOGEN CONTAINING CYCLOHEXANE DERIVATIVES, METHODS OF PREPARATION AND COMPOSITIONS CONTAINING SAME | FRITZSCHE DODGE & OLCOTT INC. (US) | 1985-01-23 | — | — | EP | claimed |
| EP-0047317-A4 | HALOGEN CONTAINING CYCLOHEXANE DERIVATIVES, METHODS OF PREPARATION AND COMPOSITIONS CONTAINING SAME. | FRITZSCHE DODGE & OLCOTT INC (US) | 1982-07-13 | — | — | EP | claimed |
| EP-0047317-A1 | HALOGEN CONTAINING CYCLOHEXANE DERIVATIVES, METHODS OF PREPARATION AND COMPOSITIONS CONTAINING SAME. | FRITZSCHE DODGE & OLCOTT INC (US) | 1982-03-17 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014065-A1 | PHYTOCHEMICAL INFUSED COSMETIC COMPOSITIONS AND THERAPEUTIC USES THEREOF | DHCR24, CNR2, DSG1 | PTPN2 3948/4885PTPN1 4244/4885UGT2B7 94/4885 |
| US-20250325463-A1 | COMPOSITIONS (III) | NISCH, TAS1R3, TAS2R3 | PTPN2 2517/4885PTPN1 2530/4885UGT2B7 2176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.